“…polyclonal pattern in TRG targets (TRB not analyzed). T3N0M0 | Capsulectomy | CR (Follow-up 24 months) | Malata M. C., et al [ 13 ] | 51 | 21 | No | FA-DLBCL | HIV | CD30 + , CD45 + , PAX5 + , CD79A + , BCL2 + , MUM1 + , BCL6 + , CD10 - , CD138 - | CD30 + , CD45 + , CD3 - , CD5 - , CD2 - , ALK - | CD138 - , HHV8 - , MIB-1 proliferation index: 80% | NA | NA | T2/3N0M0 Small volume axillary nodes on CT | Capsulectomy | CR (Follow-up 24 months) |
Khoo C., et al [ 14 ] | 70 | 9 | No | FA-DLBCL | Unknown | CD30 + , CD45 + , CD79A + , CD20 + , PAX5 + , BCL6 + , MUM1 + , PD-L1 + (SP142 clone), CD10 - | CD45 + , CD30 + , CD3 - , CD2 - , CD4 - , CD5 - , CD7 - , CD8 - , TIA1 - , perforin - , Granzyme B - , ALK - | CD68 - , AE1 - /AE3 - , Cam 5.2 - , EMA - , HHV-8 - | NA | Monoclonal peak in IHC rearrangement | T3N0M0 | Capsulectomy | CR (Follow-up 12 months) |
Mescam L., et al [ 10 ] | 72 | NA | No | intermediate features between CI- and FA-DLBCL | Unknown | CD30 ... |
…”